Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
JXHL1300456 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2013-12-02 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-05-04 | view |
JXHL1300455 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2013-12-17 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-05-04 | view |
JXHL1400266 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2014-07-23 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-10-27 | view |
JXHL1400265 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2014-07-31 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-10-27 | view |
JXHL1500090 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2015-04-30 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-12-31 | view |
JXHL1500091 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2015-04-30 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-12-31 | view |
JXHL1700167 | LY2157299 | galunisertib | Other | Chemical Drugs(1) | Import Drug Application | 2017-09-06 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia | Certificate Issued | 2018-03-01 | view |
JXHL1700168 | LY2157299 | galunisertib | Other | Chemical Drugs(1) | Import Drug Application | 2017-09-06 | 美国礼来亚洲公司上海代表处 | Shanghai Representative Office of Eli Lilly Asia | Certificate Issued | 2018-03-01 | view |